BioSpace News Archive

Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious and rare diseases, today announced the company’s support for Rare Disease Day 2019 for patients living with hereditary transthyretin (hATTR) amyloidosis and familial chylomicronemia syndrome (FCS) and their caregivers, including bringing several of them together to participate in a live panel discussion related to their disease.

MGC Diagnostics Corporation (MGCD), through its Medical Graphics and Medisoft subsidiaries, is a global medical technology company dedicated to the delivery of diagnostic solutions for detecting, classifying, and managing cardiorespiratory disease

Ergomed plc (LSE: ERGO) (‘Ergomed’ or the ‘Company’), a specialised pharmaceutical services and drug development company, together with its rare disease subsidiary PSR Group BV (‘PSR Orphan Experts’), a specialised contract research organisation focusing on orphan drug development, today announced their support of this year’s Rare Disease Day® held on February 28th.

Amryt, a revenue generating orphan drug company focused on acquiring, developing & commercialising products that help to improve the lives of patients where there is a high unmet medical need, today announces an update on its pivotal Phase III EASE trial for AP101 as a potential treatment for Epidermolysis Bullosa (“EB”).

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the availability of new product solutions for its Twist Human Core Exome Kit and Twist Custom Panels next-generation sequencing (NGS) target enrichment workflows, allowing customers to move from sample to sequencer in a single day.

March is Red Cross Month, and the American Red Cross asks everyone to be a hero in their community by becoming a volunteer, learning lifesaving skills, giving blood or donating to #help1family on Red Cross Giving Day, March 27.

CP Kelco and Intrinsic Organics join as Executive Board Members, BioNeutra and Top Health Ingredients join as Members and Atlantia Food Clinical Trials and MSPrebiotics join as Associate Members

Company also provides update on upcoming presentation from a Phase 2 proof-of-concept study and Phase 3 pivotal trial status

Advisory Board includes executives from Ada Health, Alarm.com, Comcast, Life365, MDLIVE, Omron, and Papa

New NCCN Guidelines for Patients: Squamous Cell Skin Cancer explains risk factors and treatment options for cancer type that impacts millions every year.